Related Experiment Video
Updated: Jun 5, 2026
09:36
Polyethyleneimine-coated Iron Oxide Nanoparticles as a Vehicle for the Delivery of Small Interfering RNA to Macrophages In Vitro and In Vivo
Published on: February 5, 2019
Polyelectrolyte complex optimization for macrophage delivery of redox enzyme nanoparticles
Yuling Zhao1, Matthew J Haney, Natalia L Klyachko
1Center for Drug Delivery & Nanomedicine, 985830 Nebraska Medical Center, Omaha, NE, USA.
Nanomedicine (London, England)
|December 25, 2010
Summary
Cell-mediated drug delivery using nano-catalase shows promise for Parkinson's disease. Specific nanozyme formulations protect enzyme activity within macrophages, enhancing therapeutic potential for neuroprotection.
Area of Science:
- Biomedical Engineering
- Neuroscience
- Drug Delivery
Background:
- Cell-mediated drug delivery offers a novel strategy for treating neurodegenerative diseases like Parkinson's disease.
- Macrophages loaded with nanoformulated catalase (nanozyme) have previously shown neuroprotective effects in Parkinson's disease models.
- Encapsulating catalase within block ionomer complexes prevents its degradation by macrophages.
Purpose of the Study:
- To investigate the relationship between block ionomer complex composition and structure.
- To evaluate the physicochemical characteristics, loading, release, and enzymatic activity of nanozymes within macrophages.
- To identify optimal nanozyme formulations for cell-mediated drug delivery in Parkinson's disease.
Main Methods:
- Synthesized and characterized various block ionomer complexes with different block copolymers.
- Loaded nanoformulated catalase into bone marrow-derived macrophages.
- Assessed nanozyme loading, release kinetics, enzymatic activity, and cytotoxicity.
- Evaluated the protective effect of nanozymes on catalase activity within macrophages.
Main Results:
- Block ionomer complex formation improved aggregation stability.
- Certain formulations (ε-polylysine and poly(L-glutamic acid)-poly(ethylene glycol)) exhibited low cytotoxicity and high loading/release rates.
- These specific formulations did not adequately protect catalase activity within macrophages.
Conclusions:
- Nanozymes utilizing polyethyleneimine and poly(L-lysine)(10)-poly(ethylene glycol) demonstrated superior protection of catalase enzymatic activity.
- These optimized nanozymes are promising for cell-mediated drug delivery applications in Parkinson's disease.
- Further development of nanozyme formulations is crucial for effective neuroprotection.
